Similar articles

• Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease.

  Roses AD. Roses AD. J Neuropathol Exp Neurol. 1994 Sep;53(5):429-37. doi: 10.1097/00005072-199409000-00002. J Neuropathol Exp Neurol. 1994. PMID: 8083686 Review. No abstract available.
• APOE modifies the association between Aβ load and cognition in cognitively normal older adults.

  Kantarci K, Lowe V, Przybelski SA, Weigand SD, Senjem ML, Ivnik RJ, Preboske GM, Roberts R, Geda YE, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr. Kantarci K, et al. Neurology. 2012 Jan 24;78(4):232-40. doi: 10.1212/WNL.0b013e31824365ab. Epub 2011 Dec 21. Neurology. 2012. PMID: 22189452 Free PMC article.
• Influence of amyloid and APOE on cognitive performance in a late middle-aged cohort.

  Mielke MM, Machulda MM, Hagen CE, Christianson TJ, Roberts RO, Knopman DS, Vemuri P, Lowe VJ, Kremers WK, Jack CR Jr, Petersen RC. Mielke MM, et al. Alzheimers Dement. 2016 Mar;12(3):281-91. doi: 10.1016/j.jalz.2015.09.010. Epub 2015 Nov 19. Alzheimers Dement. 2016. PMID: 26602629 Free PMC article.
• Apolipoprotein E, A beta-amyloid, and the molecular pathology of Alzheimer's disease. Therapeutic implications.

  Kaplitt M, Gouras GK, Makimura H, Jovanovic J, Sweeney D, Greengard P, Relkin NR, Gandy S. Kaplitt M, et al. Ann N Y Acad Sci. 1996 Dec 16;802:42-9. doi: 10.1111/j.1749-6632.1996.tb32597.x. Ann N Y Acad Sci. 1996. PMID: 8993483 No abstract available.
• [Molecular mechanism underlying the development of Alzheimer's disease: implications of apolipoprotein E and presenilin].

  Yanagisawa K. Yanagisawa K. Nihon Ronen Igakkai Zasshi. 2001 Jul;38(4):455-7. Nihon Ronen Igakkai Zasshi. 2001. PMID: 11523146 Review. Japanese. No abstract available.